Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-08 5:44 pm Unchanged | 2024-09-30 | 13G | Foghorn Therapeutics Inc. FHTX | Klarman Family Foundation | 2,139,639 3.900% | 0 (Unchanged) | Filing History |
| 2024-09-20 6:00 pm Purchase | 2024-09-13 | 13G | Foghorn Therapeutics Inc. FHTX | James E. Flynn | 2,935,295 5.310% | 2,935,295 (New Position) | Filing History |
| 2024-06-10 09:48 am Purchase | 2024-06-07 | 13G | Foghorn Therapeutics Inc. FHTX | FMR LLC | 6,303,217 11.392% | 3,493,208 (+124.31%) | Filing History |
| 2024-05-30 4:51 pm Purchase | 2024-05-20 | 13G | Foghorn Therapeutics Inc. FHTX | BIOTECHNOLOGY VALUE FUND L P | 5,552,341 9.990% | 5,552,341 (New Position) | Filing History |
| 2024-05-24 5:00 pm Purchase | 2024-05-22 | 13D | Foghorn Therapeutics Inc. FHTX | Flagship Ventures Fund V, L.P. | 16,303,949 22.900% | 3,629,829 (+28.64%) | Filing History |
| 2024-02-09 09:03 am Sale | 2024-02-08 | 13G | Foghorn Therapeutics Inc. FHTX | FMR LLC | 2,810,009 6.656% | -307,385 (-9.86%) | Filing History |
| 2023-02-09 10:59 am Purchase | 2023-02-09 | 13G | Foghorn Therapeutics Inc. FHTX | FMR LLC | 3,117,394 7.457% | 632,560 (+25.46%) | Filing History |
| 2022-02-09 09:20 am Sale | 2022-02-08 | 13G | Foghorn Therapeutics Inc. FHTX | FMR LLC | 2,484,834 6.699% | -95,800 (-3.71%) | Filing History |
| 2021-12-13 08:16 am Purchase | 2021-12-10 | 13G | Foghorn Therapeutics Inc. FHTX | ELI LILLY & Co LLY | 4,000,000 9.700% | 4,000,000 (New Position) | Filing History |
| 2021-04-19 09:11 am Purchase | 2020-12-31 | 13G | Foghorn Therapeutics Inc. FHTX | KADOCH CIGALL | 3,957,712 11.050% | 3,957,712 (New Position) | Filing History |
| 2021-02-08 10:21 am Purchase | 2021-02-05 | 13G | Foghorn Therapeutics Inc. FHTX | FMR LLC | 2,580,634 7.041% | 2,580,634 (New Position) | Filing History |
| 2021-02-03 6:27 pm Purchase | 2020-12-31 | 13G | Foghorn Therapeutics Inc. FHTX | Klarman Family Foundation | 2,139,639 5.970% | 2,139,639 (New Position) | Filing History |
| 2020-10-29 5:00 pm Purchase | 2020-10-27 | 13D | Foghorn Therapeutics Inc. FHTX | Flagship Ventures Fund V, L.P. | 12,674,120 35.500% | 12,674,120 (New Position) | Filing History |